Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

What is Metabolism?

What is Metabolism?

Seedless Vascular Plants

Seedless Vascular Plants

Seedless Vascular Plants Were the First Tall Plants on Earth

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pulmonary Vascular Signaling in Pulmonary Hypertension: Potential Role of Endothelial Ca<sup>2+</sup> Signaling in Cellular Senescence and Inflammasome Activation.

Arteriosclerosis, thrombosis, and vascular biology·2026

Same author

Guidelines for evaluating endothelial function in vascular tissue.

American journal of physiology. Heart and circulatory physiology·2026

Same author

Implementing a trauma-informed approach in a tiered model of pediatric population mental health care: a pilot study in primary and secondary care.

BMC health services research·2025

Same author

Enhancing Accuracy of Newborn Screening for 21OHD: Strategic Use of 21-Deoxycortisol in a Large-Scale Tokyo Cohort.

The Journal of clinical endocrinology and metabolism·2025

Same author

Correction of the Murine Model of Congenital Heart Disease Associated With the <i>Nkx2-5</i> Mutation Using Prime Editing.

Circulation. Genomic and precision medicine·2025

Same author

Store-operated Ca<sup>2+</sup> entry is involved in endothelium-to-mesenchymal transition in lung vascular endothelial cells.

American journal of physiology. Lung cellular and molecular physiology·2025

Search research articles

Related Experiment Video

Updated: Feb 6, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

Pulmonary vascular dysfunction in metabolic syndrome.

Conor Willson¹, Makiko Watanabe¹, Atsumi Tsuji-Hosokawa¹

¹Department of Physiology, University of Arizona, Tucson, AZ, USA.

The Journal of Physiology

|August 21, 2018

Summary

Metabolic syndrome, a precursor to cardiovascular disease, impacts pulmonary vascular function. This review details how metabolic syndrome affects the pulmonary vasculature, potentially increasing risks for pulmonary hypertension.

Keywords:

Diabetes Insulin resistance dyslipidemia obesity pulmonary artery pulmonary hypertension

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Related Experiment Videos

Last Updated: Feb 6, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Area of Science:

Cardiovascular Science
Pulmonary Medicine
Metabolic Disorders

Background:

Metabolic syndrome is a significant risk factor for cardiovascular disease, the leading global cause of death.
Key risk factors include hyperglycemia, abdominal obesity, dyslipidemia, and hypertension.
Metabolic syndrome is known to affect vascular endothelial and smooth muscle cells in various organs.

Purpose of the Study:

To review the effects of metabolic syndrome on pulmonary vascular function.
To explore the link between metabolic syndrome and pulmonary vascular diseases like pulmonary hypertension.

Main Methods:

Literature review of existing studies on metabolic syndrome and pulmonary vasculature.
Analysis of how metabolic syndrome components influence pulmonary vascular cells and function.

Main Results:

Metabolic syndrome significantly alters pulmonary vascular endothelial and smooth muscle cell functions.
These alterations contribute to increased risk of pulmonary vascular diseases, including pulmonary hypertension.

Conclusions:

Metabolic syndrome poses a considerable threat to pulmonary vascular health.
Further research is needed to fully elucidate the mechanisms linking metabolic syndrome to pulmonary vascular dysfunction and disease.